Evaluation of Antipruritic Effects of Serlopitant, a Neurokinin 1 Receptor Antagonist, in Patients with Epidermolysis Bullosa: A Phase 2 Randomized Controlled Trial.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY(2024)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要